###### Key questions

What is already known about this subject?
=========================================

Tricuspid annular plane systolic excursion (TAPSE) and fractional area change (FAC) are commonly used echocardiographic quantitative estimates of right ventricular (RV) function. There has yet to be a systematic overview that would provide a more precise estimate of the accuracy of TAPSE and FAC in their assessment of RV systolic function (RVSF).

What does this study add?
=========================

Systematic analysis of 17 studies revealed that FAC had a higher correlation with cardiac MRI-derived RV ejection fraction compared with TAPSE.

How might this impact on clinical practice?
===========================================

Adoption of FAC as a routine tool for the assessment of RVSF should be considered and should be performed in addition to TAPSE when possible.

Introduction {#s1}
============

Right ventricular (RV) function is an important predictor of outcome in a variety of cardiovascular diseases and therefore, a precise evaluation of RV function is essential.[@R1] However, the unique geometry of the right ventricle poses difficulty in volume and hence ejection fraction assessments by two-dimensional (2D) echocardiography, in both normal and disease states. An accurate evaluation of RV function remains challenging in clinical practice, due to the absence of any widely accepted 2D echocardiographic methods to assess RV systolic function (RVSF).

Traditional echocardiographic surrogates of RV ejection fraction (RVEF) include tricuspid annular plane systolic excursion (TAPSE) and fractional area change (FAC). TAPSE is a one-dimensional measure of RVSF and assumes that the displacement of basal and adjacent segments of the RV represents the entire RV function. By contrast, FAC is a 2D parameter. There have been multiple studies evaluating the accuracy of various 2D echocardiographic parameters by comparing them with the gold standard, cardiac MRI (CMRI)-derived RVEF. However, studies are limited by their small sample size. There has yet to be a systematic overview that would provide a more precise estimate of the accuracy of TAPSE and FAC in their assessment of RVSF. In our study, we aim to summarise available data on TAPSE and FAC and compare their accuracy in the measurement of RV function.

Methods {#s2}
=======

A systematic literature review was planned and performed using methods specified in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic review.[@R4] Both controlled vocabulary terms (eg, MeSH) and key words were used to search for articles comparing TAPSE and FAC to CMRI-derived RVEF. The following databases were searched:

Ovid/MEDLINE (1946--2016); Elsevier/EMBASE (1947--2016); Wiley/Cochrane Library (1898 −2016); Thomson-Reuters/Web of Science (1898--2016); and ClinicalTrials.gov (1997--2016).

Literature searches were completed on 18 April 2016. The complete Ovid/MEDLINE search strategy, analogous to the other database searches, is available in [appendix A](#SP1){ref-type="supplementary-material"}.
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No publication date or language limit was applied.

Study selection {#s2a}
---------------

Studies were considered eligible if they assessed RVSF with TAPSE or FAC derived from 2D echocardiography and RVEF derived from CMRI. Our prespecified selection criteria were as follows[@R1]: studies with patients undergoing both 2D echocardiography and CMRI,[@R2] TAPSE, FAC data and CMRI-derived RVEF obtained in the same patient,[@R3] human studies. We did not limit the scope of indications for echocardiography and CMRI to be included in our meta-analysis. Exclusion criteria were[@R1]: studies based on congenital heart disease,[@R2] case reports, review articles, commentaries and editorials. Two independent reviewers performed the study selection (JL, SL). In case of disagreements, a third reviewer (AP) cast the deciding vote. Titles and abstracts of retrieved references were screened for inclusion and full texts of potential articles were further analysed to see if they met inclusion criteria ([figure 1](#F1){ref-type="fig"}).

![Study selection diagram.](openhrt-2017-000667f01){#F1}

Data extraction {#s2b}
---------------

The following information was extracted from each study: study name, study authors, year of publication, type of manuscript and demographic profiles including number of subject, background disease, median age and gender. We also extracted mean TAPSE, mean FAC, mean CMRI-derived RVEF, TAPSE correlation coefficient with CMRI-derived RVEF and FAC correlation coefficient with CMRI-derived RVEF and P values from each study.

Statistical analysis {#s2c}
--------------------

Mean TAPSE and FAC to CMRI-derived RVEF correlation coefficient from each study were weighted based on number of patients in each study relative to the total number of patients. Paired Student t-test analysis was used as comparison data were obtained from the same patient in each study. Mean difference of mean correlation coefficients was calculated. Similar statistical methodology was used to perform subgroup analyses of patients with pulmonary hypertension (PH). We used IBM SPSS Statistics (V.22 for Windows) for the calculation of paired Student t-test.

Results {#s3}
=======

We found 7450 articles through database searching. Of the 5283 articles that remained after duplicates were removed, 4990 were excluded due to irrelevance to the topic ([figure 1](#F1){ref-type="fig"}). Strict inclusion and exclusion criteria as outlined above were applied to the full text of 293 articles. Of these, 17 prospective and retrospective studies met full criteria and when combined for this meta-analysis included 1280 patients.

Study characteristics {#s3a}
---------------------

[Table 1](#T1){ref-type="table"} describes the baseline characteristics of included studies. The 17 studies comprised 10 full papers[@R5] and 7 abstracts.[@R15] There was a mixture of prospective and retrospective studies. The pooled patient population included healthy patients as well as patients with idiopathic cardiomyopathy, ischaemic heart disease, PH and end-stage lung disease. The mean age was 51±9 years with men accounting for 54% of subjects. In each included study, patients underwent 2D echocardiogram and had both TAPSE and FAC measured. This was followed by CMRI with measurement of RVEF.

###### 

Characteristics of included studies

  No                                 Author                           Year    Type of manuscript   Number of patients   Patient population                                                       Mean age (year)   Man, %   TAPSE EF (mm)   TAPSE correlation coefficient   P value for TAPSE   FAC EF (%)   FAC correlation coefficient   P value    CMR RVEF (%)
  ---------------------------------- -------------------------------- ------- -------------------- -------------------- ------------------------------------------------------------------------ ----------------- -------- --------------- ------------------------------- ------------------- ------------ ----------------------------- ---------- --------------
  1\.                                Anavekar *et al*                 2007    Paper                36                   Patient undergoing assessment of ischaemia or viability                  59±12             63       NA              0.17                            \<0.30              NA           0.8                           \<0.0001   55±8.9
  2\.                                Arnould *et al*                  2009    Paper                19                   Mixed population with EF [≤]{.ul}45%                                     NA                NA       18.8±5.7        0.472                           0.006               33±11        0.684                         0.000      29.53±10.29
  13                                 Mixed population with EF \>45%   NA      NA                   21.2±5.1             0.006                                                                    47±8              0.000    55.6±5.4                                                                                                                  
  3\.                                Chen *et al*                     2011    Abstract             60                   All clinical patients referred for CMR also underwent echocardiography   45                60       NA              0.48                            0.01                NA           0.56                          \<0.001    50%
  4\.                                Focardi *et al*                  2015    Paper                63                   Mixed population with RVEF [≤]{.ul}45%                                   46±17             49       18.2±4.4        0.45                            0.01                42.2±11      0.77                          \<0.0001   40.1±4.8
  Mixed population with RVEF\> 45%   43±17                            48      23.2±4.6             NA                   NA                                                                       55.4±11           NA       NA              58.8±8.2                                                                                                  
  5\.                                Freed *et al*                    2012    Abstract             25                   PAH                                                                      NA                NA       NA              0.47                            NA                  NA           0.63                          NA         35±14
  6\.                                Grover *et al*                   2011    Abstract             90                   Mixed population                                                         61                NA       NA              0.65                            \<0.001             NA           0.53                          0.002      NA
  7\.                                Lemarie *et al*                  2015    Paper                135                  AMI                                                                      55±11             87       21.8±4.5        0.267                           0.002               43.8±9.6     0.368                         \<0.0001   54.8±6.2
  8\.                                Li *et al*                       2015    Paper                32                   CTEPH                                                                    55±12             53       13.74±2.29      0.451                           0.22                29.9±9.01    0.423                         0.022      39±9
  9\.                                Maceira Gonzales *et al*         2010    Abstract             40                   Mixed population                                                         NA                NA       NA              0.80                            \>0.001             NA           0.76                          \>0.001    NA
  10\.                               Pavlicek *et al*                 2011    Paper                129                  RVEF ≥50%                                                                44±19             70       20±6            0.34                            \<0.0001            41±13        0.47                          \<0.0001   61±7
  67                                 RVEF \>30%--49%                  41±18   66                   17±6                 33±11                                                                    44±3                                                                                                                                                 
  27                                 RVEF ≤30%                        53±20   85                   13±5                 23±8                                                                     28±2                                                                                                                                                 
  11\.                               Renard *et al*                   2014    Abstract             61                   PH                                                                       57±16             47       NA              0.48                            NA                  NA           0.51                          NA         NA
  12\.                               Sato *et al*                     2012    Paper                37                   PAH                                                                      53±15             30       19±4            0.86                            NA                  31±17        0.4                           NA         38±11
  13\.                               Shiran *et al*                   2O14    Paper                40                   PAH                                                                      42±12             15       NA              0.8                             \<0.001             NA           0.87                          \<0.001    35±15
  14\.                               Spruijt *et al*                  2017    Paper                96                   PH                                                                       53±16             28       18.8±4          0.485                           NA                  35.8±11.4    0.753                         NA         41.4±15.2
  15\.                               Takemoto *et al*                 2015    Abstract             142                  NA                                                                       55±18             54       NA              0.22                            0.0121              NA           0.596                         \<0.0001   NA
  16\.                               Yang *et al*                     2013    Paper                30                   PAH                                                                      30±10             20       16.3±2.7        0.440                           0.015               28.9±7.0     0.416                         0.022      27±12
  17\.                               Zhou *et al*                     2015    Abstract             125                  NA                                                                       55±16             51       19.6±5.4        0.12                            0.4                 42.9±9.1     0.43                          0.003      53.6±11.6

CMR, cardiac magnetic resonance; CTEPH, chronic thromboembolic pulmonary hypertension; EF, ejection fraction; FAC, fractional area change; PAH, pulmonary arterial hypertension; PH, pulmonary hypertension; RVEF, right ventricular ejection fraction; TAPSE, tricuspid annular plane systolic excursion.

Comparison of TAPSE and FAC {#s3b}
---------------------------

Composite mean correlation coefficient from each study revealed that FAC had a higher mean correlation coefficient (r) of 0.56 (SE of 0.08) compared with TAPSE, which had a mean correlation coefficient (r) of 0.40 (SE of 0.06) ([figure 2](#F2){ref-type="fig"}). This difference was statistically significant (P=0.018).

![Comparison of mean correlation coefficient in TAPSE and FAC. FAC, fractional area change; TAPSE, tricuspid annular plane systolic excursion.](openhrt-2017-000667f02){#F2}

Pulmonary hypertension {#s3c}
----------------------

Pooled data from 321 patients with PH revealed that TAPSE had a mean correlation coefficient of 0.46 (SE of 0.07) and FAC had a mean correlation coefficient of 0.57 (SE of 0.12) ([figure 3](#F3){ref-type="fig"}). This difference was not statistically significant (P=0.16).

![Comparison of mean correlation coefficient in TAPSE and FAC in PH. FAC, fractional area change; PH, pulmonary hypertension;TAPSE,  tricuspid annular plane systolic excursion.](openhrt-2017-000667f03){#F3}

Discussion {#s4}
==========

Our meta-analysis involving 1280 patients from 17 studies revealed the following findings:

(1) overall analysis revealed FAC to have significantly higher correlation with CMRI-derived RVEF compared with TAPSE; (2) in patients with PH, both TAPSE and FAC had similar correlation with CMRI-derived RVEF.

The right ventricle has a complex geometry. It is triangular when viewed from the side and crescentic when viewed in cross-section.[@R22] Anatomically, the RV can be subdivided into three parts; an inlet portion, a highly trabeculated body and a smooth outlet portion, known as the conus or infundibulum. RVSF can be assessed using 2D echocardiography by various direct and indirect measurements.[@R23] Direct measurements include TAPSE; systolic velocity (s') as measured by tissue Doppler imaging; FAC measured by tracing the area during systole and diastole; and RV index of myocardial performance, where both systolic and diastolic components are included. Indirect measurements include relative volumes of RV and LV; degree of septal flattening; angle created at the RV apex[@R24]; and various Doppler indices such as RV dP/dT and tricuspid regurgitation duration indexed to heart rate.[@R25] In our study, we compared TAPSE, a simple and common method of measuring RVSF, with FAC, one of the better 2D echocardiographic methods of assessing RVSF.[@R5] CMRI is regarded as the reference method for assessing RV function and has been shown to have good correlation with in vivo standards, with good accuracy and reproducibility.[@R26]

Our overall pooled analysis revealed FAC to be a more accurate measurement of RVEF compared with TAPSE. This is likely because TAPSE is a one-dimensional measurement, whereas FAC is a 2D measurement. In situations where there are regional differences in the RV function, TAPSE does not always provide accurate information due to the fact that it disregards the transverse contribution of RV free wall and septum. TAPSE was also noted to be markedly depressed after cardiac surgery when three-dimensional echo showed preserved RVEF, suggesting that it is affected by postoperative changes in the geometry of RV contraction.[@R28] FAC, in addition to including the longitudinal shortening fraction, also incorporates the changes that occur in the transverse plane. In situations where regional differences in RV function are noted, FAC may provide better estimates. A study by Sakuma *et al* using cineangiography to assess RVEF revealed a significant contribution of transverse systolic shortening to RVEF.[@R30]

Our study also found that in patients with PH, no significant difference was found between TAPSE and FAC. This is likely because the longitudinal component of RV contraction represents the afterload-responsive element of RV function.[@R31] This is measured in both TAPSE and FAC and therefore, there may not be a difference between their accuracy of measurement of RVSF among patients with PH. A prior study has also suggested that pseudo-normalisation of TAPSE may occur in PH due emergence of a 'rocking' pattern from compression of a pressure-loaded right heart on a compliant left heart.[@R32] The systolic function of this 'rocking' right ventricle may be better analysed using speckle-tracking echocardiography, as opposed to translational parameters such as TAPSE or velocity of the tricuspid annular systolic motion (RV S').

Compared with TAPSE, FAC may require a better image quality of the right ventricle in order to trace the RV endocardium to calculate FAC. However, this should not be a reason to deter the use of FAC, as it is a more accurate assessment of RVEF. More studies will have to be done to determine the intraobserver and interobserver variabilities of the use of TAPSE and FAC and its impact on accuracy. RV FAC has also been found to be an independent predictor of heart failure, sudden death, stroke and mortality.[@R1] This provides significant justification for the usage of FAC as a reliable surrogate of RVSF.

Limitations {#s4a}
-----------

This meta-analysis is based on extrapolated data from multiple studies. We were not able to obtain individual patient level data from each study. Abstracts were also included in our study in order to avoid publication bias. However, the limitation of inclusion of abstracts is that they receive less editorial scrutiny and may have been vetted less when compared with a full paper publication. Another limitation is the possible variability in time delay from echocardiogram to MRI. However, although the exact time between echocardiogram to MRI was not reported, each study only included patients who were in stable clinical condition and therefore, significant variation of RV function between imaging periods were not expected. Another potential limitation is that there may be interstudy and intrastudy variability that may affect the conclusion of our analysis. Lastly, the percentage of uninterpretable images due to poor imaging quality were not reported in some studies and could not be included in the analysis.

Conclusion {#s5}
==========

The results of this meta-analysis suggest that FAC provides a more accurate estimate of RVSF compared with TAPSE. Adoption of FAC as a routine tool for the assessment of RVSF should be considered, especially since it is also an independent predictor of morbidity and mortality. Further studies will be needed to compare other echocardiographic measurements of RVEF.
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